Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Research

Supporting academic research within and outside of the university, we provide specialist analytical chemistry support in the majority through HPLC-MS or HPLC-MS-MS techniques with additional UV-visible absorbance and fluorescence detection abilities.
Bioanalysis

Supporting academic research within and outside ...

The Early Phase Clinical Trials Unit (EPCTU) aims to support the translation of research findings in to clinical practice.
Early Phase Clinical Trials Unit

The Early Phase Clinical Trials Unit (EPCTU) aims ...

Flow cytometry determines the 'what', the 'where' and the 'how much' of material in cells, and is an important step in testing effects of drug interventions.
Flow Cytometry

Flow cytometry determines the 'what', the 'where' ...

The Live Tissue Facility is designed to boost the translational impact of oncological research without users having to independently create ethics applications and collection logistics.
Live Tissue Facility

The Live Tissue Facility is designed to boost the ...

The Mechanical Workshop delivers an on-site fabrication facility for custom-made, precision mechanical items for use in scientific research.
Mechanical Workshop

The Mechanical Workshop delivers an on-site ...

The Microscopy SRF aims to provide research groups with imaging technologies to investigate cellular processes both in vitro and in vivo.
Microscopy

The Microscopy SRF aims to provide research ...

The Oncology Clinical Trials Office (OCTO) provides clinical trial management support to investigators across the CRUK Oxford Centre to manage trials from concept to completion.
Oncology Clinical Trials Office (OCTO)

The Oncology Clinical Trials Office (OCTO) ...

The PET Radiochemistry and Radiopharmacy core supports radiochemistry-dependent research programmes and provide GMP-grade PET radiopharmaceuticals for clinical trials.
PET Radiochemistry and Radiopharmacy (PROx)

The PET Radiochemistry and Radiopharmacy core ...

State-of-the art platforms for in vivo study of disease models
Pre-Clinical Imaging

State-of-the art platforms for in vivo study of ...

Proteomics studies proteins on a large scale. Proteins are vital to living organisms and their multi-functional characteristics act as potential targets for drug therapies. Therefore, proteomics can be used for biomarker and target discovery, drug profiling and target validation.
Proteomics

Proteomics studies proteins on a large scale. ...

The Radiation Biophysics Facility develops and supports a unique range of radiation resources and techniques along with providing associated expertise.
Radiation Biophysics

The Radiation Biophysics Facility develops and ...

We provide tools, skills and training on analysis of biomedical data. Our expertise covers areas ranging from applied statistics to computational and functional genomics.
The Bioinformatics Hub

We provide tools, skills and training on analysis ...

Translational Histopathology
Translational Histopathology

Key Research Links

Latest Research News

Professor Anna Schuh awarded funding from the NIHR RIGHT programme

The NIHR has invested £34 million of funding into global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs).

IF Oxford Science and Ideas Festival

Clinical Trials are both science and an important idea. On 20 Oct the Department of Oncology took its place in the main chamber of the Oxford Town Hall as part of the IF Oxford Science and Ideas Festival 2019.

A tempting new target for cancer therapy

Kristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.

More news